XML 39 R24.htm IDEA: XBRL DOCUMENT
v3.21.2

Organization and Significant Accounting Policies - Additional Information (Detail) |  |  |  |  | 1 Months Ended | 9 Months Ended |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Jun. 18, 2021 USD ($) | Oct. 07, 2020 USD ($) | Oct. 03, 2018 USD ($) Target | Sep. 28, 2016 USD ($) | Jul. 31, 2021 USD ($) | Jan. 31, 2021 USD ($) | Jun. 30, 2021 USD ($) | Jun. 30, 2020 USD ($) | May 31, 2021 USD ($) | Sep. 30, 2020 USD ($) | Jul. 31, 2020 USD ($)
Organization And Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Cash received as due under agreement |  |  |  |  |  | $ 300,000,000.0 |  |  |  |  |
Proceeds from the issuance of common stock |  |  |  |  |  |  |  | $ 250,479,000 |  |  |
Cash and cash equivalents |  |  |  |  |  |  | $ 325,981,000 |  |  | $ 143,583,000 |
Restricted Cash |  |  |  |  |  |  | 2,400,000 |  |  |  |
Short-term investments |  |  |  |  |  |  | 63,924,000 |  |  | 86,890,000 |
Marketable securities |  |  |  |  |  |  | 126,400,000 |  |  |  |
Long-term investments |  |  |  |  |  |  | 128,376,000 |  |  | $ 137,487,000 |
Net increase (decrease) in cash and investments |  |  |  |  |  |  | $ 191,700,000 |  |  |  |
ASU No. 2018-18 |  |  |  |  |  |  |  |  |  |  |
Organization And Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Change in accounting principle, accounting standards update, adopted [true false] |  |  |  |  |  |  | true |  |  |  |
Change in accounting principle, accounting standards update, adoption date |  |  |  |  |  |  | Oct. 01, 2020 |  |  |  |
Change in accounting principle, accounting standards update, immaterial effect [true false] |  |  |  |  |  |  | true |  |  |  |
ASU No. 2018-15 |  |  |  |  |  |  |  |  |  |  |
Organization And Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Change in accounting principle, accounting standards update, adopted [true false] |  |  |  |  |  |  | true |  |  |  |
Change in accounting principle, accounting standards update, adoption date |  |  |  |  |  |  | Oct. 01, 2020 |  |  |  |
Change in accounting principle, accounting standards update, immaterial effect [true false] |  |  |  |  |  |  | true |  |  |  |
Takeda License Agreement |  |  |  |  |  |  |  |  |  |  |
Organization And Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Cash received as due under agreement |  |  |  |  |  | $ 300,000,000.0 |  |  |  |  |
Profit sharing structure ratio |  | 50.00% |  |  |  |  |  |  |  |  |
Development regulatory and commercial milestones payments |  | $ 740,000,000.0 |  |  |  |  |  |  |  |  |
Takeda License Agreement | Maximum |  |  |  |  |  |  |  |  |  |  |
Organization And Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Tiered royalties received percentage |  | 25.00% |  |  |  |  |  |  |  |  |
Takeda License Agreement | Minimum |  |  |  |  |  |  |  |  |  |  |
Organization And Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Tiered royalties received percentage |  | 20.00% |  |  |  |  |  |  |  |  |
Janssen |  |  |  |  |  |  |  |  |  |  |
Organization And Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Milestone payment |  |  | $ 60,000,000.0 |  |  |  |  |  |  |  |
Milestone payments |  |  |  |  |  |  |  |  | $ 10,000,000 |  |
Janssen | ARO-JNJ1 |  |  |  |  |  |  |  |  |  |  |
Organization And Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Milestone payment |  |  |  |  |  |  |  |  | $ 10,000,000 |  |
Janssen | License Agreement |  |  |  |  |  |  |  |  |  |  |
Organization And Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Agreement date |  |  | Oct. 03, 2018 |  |  |  |  |  |  |  |
Janssen | License Agreement | Maximum |  |  |  |  |  |  |  |  |  |  |
Organization And Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Development regulatory and sales milestones payments |  |  | $ 1,600,000,000 |  |  |  |  |  |  |  |
Janssen | Collaboration Agreement |  |  |  |  |  |  |  |  |  |  |
Organization And Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Number of additional targets for development and sales milestone payments | Target |  |  | 3 |  |  |  |  |  |  |  |
Janssen | Collaboration Agreement | Maximum |  |  |  |  |  |  |  |  |  |  |
Organization And Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Development regulatory and sales milestones payments |  |  | $ 1,900,000,000 |  |  |  |  |  |  |  |
Janssen and JJDC | Collaboration and License agreements |  |  |  |  |  |  |  |  |  |  |
Organization And Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Cash received as due under agreement |  |  | 175,000,000.0 |  |  |  |  |  |  |  |
JJDC | Common Stock Purchase Agreement |  |  |  |  |  |  |  |  |  |  |
Organization And Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Proceeds from the issuance of common stock |  |  | $ 75,000,000.0 |  |  |  |  |  |  |  |
Agreement date |  |  | Oct. 03, 2018 |  |  |  |  |  |  |  |
Amgen Incorporated | Collaboration and License agreements |  |  |  |  |  |  |  |  |  |  |
Organization And Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Agreement date |  |  |  | Sep. 28, 2016 |  |  |  |  |  |  |
Amgen Incorporated | Olpasiran Agreement |  |  |  |  |  |  |  |  |  |  |
Organization And Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Milestone payment |  |  |  |  |  |  |  |  |  |  | $ 20,000,000.0
Milestone payments |  |  |  | $ 30,000,000.0 |  |  |  |  |  |  |
Amgen Incorporated | Olpasiran Agreement | Maximum |  |  |  |  |  |  |  |  |  |  |
Organization And Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Development regulatory and sales milestones payments |  |  |  |  |  |  | $ 400,000,000.0 |  |  |  |
Amgen Incorporated | License Collaboration and Stock Purchase Agreement |  |  |  |  |  |  |  |  |  |  |
Organization And Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Cash received as due under agreement |  |  |  | 35,000,000.0 |  |  |  |  |  |  |
Proceeds from the issuance of common stock |  |  |  | $ 21,500,000 |  |  |  |  |  |  |
Horizon Therapeutics Ireland DAC | Collaboration and License agreements |  |  |  |  |  |  |  |  |  |  |
Organization And Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Development regulatory and commercial milestones payments | $ 660,000,000 |  |  |  |  |  |  |  |  |  |
Agreement date | Jun. 18, 2021 |  |  |  |  |  |  |  |  |  |
Horizon Therapeutics Ireland DAC | Collaboration and License agreements | Subsequent Event |  |  |  |  |  |  |  |  |  |  |
Organization And Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |
Cash received as due under agreement |  |  |  |  | $ 40,000,000 |  |  |  |  |  |

X
- Definition Agreement date. + References No definition available. + Details
Name: | arwr_AgreementDate
Namespace Prefix: | arwr_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition Cash received as due under agreement. + References No definition available. + Details
Name: | arwr_CashReceivedAsDueUnderAgreement
Namespace Prefix: | arwr_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Development regulatory and commercial milestones payments. + References No definition available. + Details
Name: | arwr_DevelopmentRegulatoryAndCommercialMilestonesPayments
Namespace Prefix: | arwr_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Development regulatory and sales milestones payments. + References No definition available. + Details
Name: | arwr_DevelopmentRegulatoryAndSalesMilestonesPayments
Namespace Prefix: | arwr_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Increase decrease in cash and investments. + References No definition available. + Details
Name: | arwr_IncreaseDecreaseInCashAndInvestments
Namespace Prefix: | arwr_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Milestone payment earned. + References No definition available. + Details
Name: | arwr_MilestonePaymentEarned
Namespace Prefix: | arwr_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Milestone payment received. + References No definition available. + Details
Name: | arwr_MilestonePaymentReceived
Namespace Prefix: | arwr_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Number of additional targets for development and sales milestone payments. + References No definition available. + Details
Name: | arwr_NumberOfAdditionalTargetsForDevelopmentAndSalesMilestonePayments
Namespace Prefix: | arwr_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Organization and significant accounting policies. + References No definition available. + Details
Name: | arwr_OrganizationAndSignificantAccountingPoliciesLineItems
Namespace Prefix: | arwr_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Profit sharing structure ratio. + References No definition available. + Details
Name: | arwr_ProfitSharingStructureRatio
Namespace Prefix: | arwr_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Tiered royalties received percentage. + References No definition available. + Details
Name: | arwr_TieredRoyaltiesReceivedPercentage
Namespace Prefix: | arwr_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_CashAndCashEquivalentsAtCarryingValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Indicates (true false) whether accounting standards update was adopted. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 10 -Section 65 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121329987&loc=SL120154346-209984 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 65 -Paragraph 15 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 20 -Section 65 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=121483254&loc=SL120254523-199619 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 40 -Section 65 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 326 -SubTopic 10 -Section 65 -Paragraph 4 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 326 -SubTopic 10 -Section 65 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 926 -SubTopic 20 -Section 65 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 926 -SubTopic 20 -Section 65 -Paragraph 2 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 326 -SubTopic 10 -Section 65 -Paragraph 3 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=121646688&loc=SL120320025-210437 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 326 -SubTopic 10 -Section 65 -Paragraph 3 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121646688&loc=SL120320025-210437 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 65 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=120240428&loc=SL120254526-165497 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 40 -Section 65 -Paragraph 2 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 65 -Paragraph 15 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 65 -Paragraph 15 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 326 -SubTopic 10 -Section 65 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=121646688&loc=SL120254519-210437 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 65 -Paragraph 8 -Subparagraph (a) + Details
Name: | us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted
Namespace Prefix: | us-gaap_
Data Type: | xbrli:booleanItemType
Balance Type: | na
Period Type: | instant

X
- Definition Date accounting standards update was adopted, in CCYY-MM-DD format. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 65 -Paragraph 15 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 10 -Section 65 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121329987&loc=SL120154346-209984 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 20 -Section 65 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=121483254&loc=SL120254523-199619 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 326 -SubTopic 10 -Section 65 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 326 -SubTopic 10 -Section 65 -Paragraph 4 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 926 -SubTopic 20 -Section 65 -Paragraph 2 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 326 -SubTopic 10 -Section 65 -Paragraph 3 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=121646688&loc=SL120320025-210437 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 326 -SubTopic 10 -Section 65 -Paragraph 3 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121646688&loc=SL120320025-210437 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 926 -SubTopic 20 -Section 65 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079 Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 65 -Paragraph 15 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 40 -Section 65 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 65 -Paragraph 15 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 40 -Section 65 -Paragraph 2 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 326 -SubTopic 10 -Section 65 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=121646688&loc=SL120254519-210437 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 65 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=120240428&loc=SL120254526-165497 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 65 -Paragraph 8 -Subparagraph (a) + Details
Name: | us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | instant

X
- Definition Indicates (true false) whether effect from applying amendment to accounting standards is immaterial. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section S99 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=112272810&loc=d3e31010-122693 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 65 -Paragraph 15 -Subparagraph (g)(2) -URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 326 -SubTopic 10 -Section 65 -Paragraph 4 -Subparagraph (e)(1) -URI http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b)(2) -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 65 -Paragraph 8 -Subparagraph (e)(3) + Details
Name: | us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
Namespace Prefix: | us-gaap_
Data Type: | xbrli:booleanItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of investment in debt security measured at amortized cost (held-to-maturity), classified as current. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=121553693&loc=d3e26626-111562 + Details
Name: | us-gaap_HeldToMaturitySecuritiesCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of investment in debt security measured at amortized cost (held-to-maturity), classified as noncurrent. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=121553693&loc=d3e26626-111562 + Details
Name: | us-gaap_HeldToMaturitySecuritiesNoncurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of investment in marketable security. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03.4) -URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878 + Details
Name: | us-gaap_MarketableSecurities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The cash inflow from the additional capital contribution to the entity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585 + Details
Name: | us-gaap_ProceedsFromIssuanceOfCommonStock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(1)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586 + Details
Name: | us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201818Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201815Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=arwr_TakedaPharmaceuticalsUnitedStatesOfAmericaIncorporatedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=arwr_JanssenPharmaceuticalsIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=arwr_AROJNJ1Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=arwr_LicenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=arwr_CollaborationAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=arwr_JanssenPharmaceuticalsAndJohnsonAndJohnsonInnovationJJDCIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=arwr_CollaborationAndLicenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=arwr_JohnsonAndJohnsonInnovationJJDCIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=arwr_CommonStockPurchaseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=arwr_AmgenIncorporatedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=arwr_OlpasiranAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=arwr_LicenseCollaborationAndStockPurchaseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=arwr_HorizonTherapeuticsIrelandDACMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |